Back in 2017, the healthcare expenditure in the GCC was estimated to reach $104.6 billion in 2022. Now, all the pre-COVID-19 assumptions are vaporizing in thin air, and everyone is back to the drawing board.

How will the healthcare industry cope with a shift that was uncalled for? How will it adapt to the changes in patients’ behavioural patterns, and address their fears and arising phobias? What role will a healthcare brand play in a post-COVID-19 new normal, and how will it manage to assert its role a leading innovator in an era where health became the prime concern?

To find out the answers, download our latest white paper “Branding Healthcare” now, by filling the form.

 

DOWNLOAD
THE FULL REPORT

    error: Content is protected !!